Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biodexa Pharmaceuticals plc - American Depositary Shares (NQ: BDRX )

0.3660 UNCHANGED
Streaming Delayed Price Updated: 3:49 PM EDT, Sep 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 735
Open 0.3660
Bid (Size) 0.3559 (7)
Ask (Size) 0.3605 (3)
Prev. Close 0.3660
Today's Range 0.3660 - 0.3660
52wk Range 0.3532 - 8.810
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
How Is The Market Feeling About Biodexa Pharmaceuticals?
Via Benzinga

Performance

YTD
-86.39%
-86.39%
1 Month
-41.06%
-41.06%
3 Month
-63.03%
-63.03%
6 Month
-65.45%
-65.45%
1 Year
-93.27%
-93.27%

More News

Read More
Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
Gold Rises Sharply; Methode Electronics Shares Spike Higher
Via Benzinga
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
JOBY Stock Pops After Completing 523-Mile eVTOL Flight
Via InvestorPlace
Cancer-Focused Nano-Cap Biodexa Pharmaceuticals Stock Is Surging On Thursday - Here's Why
Via Benzinga
KZIA Stock Alert: Kazia Continues Its Surge on Thursday With 51% Gains
Via InvestorPlace
Why Is Biodexa Pharmaceuticals (BDRX) Up 56% Today?
Via InvestorPlace
Nasdaq Dips Over 300 Points; PepsiCo Reports Weak Sales
Via Benzinga
US Stocks Edge Higher; Inflation Slows To 3% In June
Via Benzinga
Topics Economy
Exposures Interest Rates
Biodexa Announces Additional Positive Results Of Phase 2 Trial Of eRapa in Treatment Of Precancerous Polyps in the GI Tract - Now 12-Month Data
Via ACCESSWIRE
Promising Phase 2 Results For Biodexa's eRapa(TM) Indicates Hope for FAP Patients Who Otherwise Have a 100% Lifetime Risk of Colorectal Cancer
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Nasdaq Falls Over 100 Points; TJX Posts Upbeat Q1 Results
Via Benzinga
Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Gold Down Over 1%; Williams-Sonoma Posts Strong Earnings
Via Benzinga
US Stocks Mixed; Target Posts Downbeat Earnings
Via Benzinga
Biodexa Pharmaceuticals Stock Is Tumbling Wednesday: What's Going On?
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Gold Moves Lower; Macy's Boosts 2024 Forecast
Via Benzinga
Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.